100%(2)100% fanden dieses Dokument nützlich (2 Abstimmungen)
346 Ansichten2 Seiten
Prevacid is a proton-pump inhibitor used to treat erosive esophagitis, duodenal and gastric ulcers, GERD, and pathological hypersecretory conditions. It works by inhibiting gastric acid secretion. Recommended adult dosages vary depending on the condition being treated, from 15 mg once daily for 4 weeks for duodenal ulcers to 15 mg once daily for up to 12 weeks for gastric ulcers or NSAID-associated ulcers. Common side effects include headache, abdominal pain, diarrhea and nausea. It should be used with caution in geriatric patients, those with liver disease, and during pregnancy or lactation.
Prevacid is a proton-pump inhibitor used to treat erosive esophagitis, duodenal and gastric ulcers, GERD, and pathological hypersecretory conditions. It works by inhibiting gastric acid secretion. Recommended adult dosages vary depending on the condition being treated, from 15 mg once daily for 4 weeks for duodenal ulcers to 15 mg once daily for up to 12 weeks for gastric ulcers or NSAID-associated ulcers. Common side effects include headache, abdominal pain, diarrhea and nausea. It should be used with caution in geriatric patients, those with liver disease, and during pregnancy or lactation.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Prevacid is a proton-pump inhibitor used to treat erosive esophagitis, duodenal and gastric ulcers, GERD, and pathological hypersecretory conditions. It works by inhibiting gastric acid secretion. Recommended adult dosages vary depending on the condition being treated, from 15 mg once daily for 4 weeks for duodenal ulcers to 15 mg once daily for up to 12 weeks for gastric ulcers or NSAID-associated ulcers. Common side effects include headache, abdominal pain, diarrhea and nausea. It should be used with caution in geriatric patients, those with liver disease, and during pregnancy or lactation.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOC, PDF, TXT herunterladen oder online auf Scribd lesen
Indications: Erosive esophagitis, duodenal ulcers, active benign gastric ulcer, short-term treatment of symptomatic GERD, healing and risk reduction of NSAID- associated gastric ulcer, Pathologic hypersecretory conditiond, including Zollinger-Ellison syndrome. Drug Classification: Antiulcer agents, proton-pump inhibitors Mechanism of Action: Binds to an enzyme in the presence of acidic gastric pH, preventing the final transport of hydrogen ions into the gastric lumen. Therapeutic effect: Diminished accumulation of acid in the gastric lumen, with lessened acid reflux. Dosage: Adult: Short-term treatment of duodenal ulcer – 15 mg od for 4 wks; maintenance of healed duodenal ulcers – 15 mg od; short-term treatment of gastric ulcers/healing of NSAID-associated gastric ulcer – 15 mg od for up to 12 wks; short-term treatment of symptomatic GERD – 15 mg od for up to 8 wk. Special Precautions: Geriatric patients; severe hepatic impairment; pregnancy, lactation, or children < 1 yr. Pregnancy Risk Category: B Adverse Reactions: CNS: headache, dizziness GI: abdominal pain, diarrhea, nausea Derm: rash. Contraindications: Hypersensitivity Forms: Delayed-release capsules – 15 mg, 30 mg; Solutabs – 15 mg, 30 mg; Delayed- release oral suspension packets – 15 mg, 30 mg Nursing Responsibilities: Assess patient routinely for epigastric or abdominal pain and for frank or occult blood in stool, emesis, or gastric aspirate. Administer before meals. Capsules may be opened and sprinkled on 1 tbsp of applesauce, pudding, cottage cheese, or yogurt and swallowed immediately for patients with difficulty swallowing. Do not crush or chew capsule contents Advise patient to avoid alcohol, products containing aspirin, or NSAIDs, and foods that may cause an increase in GI irritation.